Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell death—to survive treatment. Instead of dying, these “persister cells” leverage this sublethal signal to regrow. Because the mechanism is non-genetic, it appears much earlier than typical resistance mutations. Targeting this enzyme could help stop tumors from returning.
source https://www.sciencedaily.com/releases/2025/12/251210092022.htm
ZTE wins three Selular Award 2026 honors for AI-powered network innovation
-
ZTE has won three prestigious awards at Selular Award 2026, held on June 8,
2026, at Menara Peninsula Hotel, Jakarta. The awards recognize ZTE's
contributi...
7 hours ago
No comments:
Post a Comment